Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Kangkang Biotechnology is a digital health and medical technology company based in Beijing, China, specializing in chronic disease management with a focus on hypertension. The company operates primarily under the brand "Kangkang Blood Pressure" (康康血压), providing an integrated solution that combines smart wearable hardware, mobile applications, and cloud-based data services. Its product portfolio includes consumer-grade smart blood pressure monitors and clinical-grade 24-hour ambulatory blood pressure monitoring (ABPM) systems. By leveraging Internet of Things (IoT) technology and big data analytics, the company enables continuous cardiovascular monitoring and personalized health interventions for patients and healthcare providers. Beijing Kangkang Biotechnology aims to bridge the gap between home monitoring and clinical intervention through its comprehensive health management ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Kangkang Biotechnology.